Effect of Maalox and omeprazole on the bioavailability of trovafloxacin

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue SUPPL. B, 1997, Pages 93-97

  Teng, Renli ^a   Dogolo, Lisa C ^a   Willavize, Susan A ^a   Friedman, Hylar L ^a   Vincent, John ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; OMEPRAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0030757353     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.suppl_2.93     Document Type: Article

References (20)

1. Gooding, B. B. & Jones, R. N. (1993). In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone. Antimicrobial Agents and Chemotherapy 37, 349-53.
2. Eliopoulos, G. M., Klimm, K., Eliopoulos, C. T., Ferraro, M. J. & Moellering, R. C. (1993). In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of Gram-positive bacteria. Antimicrobial Agents and Chemotherapy 37, 366-70.
3. Neu, H. C. & Chin, N.-X. (1994). In vitro activity of the new fluoroquinolone CP-99,219. Antimicrobial Agents and Chemotherapy 38, 2615-22.
4. Teng, R., Harris, S. C., Nix, D. E., Schentag, J. J., Foulds, G. & Liston, T. E. (1995). Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. Journal of Antimicrobial Chemotherapy 36, 385-94.
5. Teng, R., Liston, T. E. & Harris, S. C. (1996). Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers. Journal of Antimicrobial Chemotherapy 37, 955-63.
6. Teng, R., Dogolo, L. C., Willavize, S. A. & Vincent, J. (1997). Oral bioavailability of trovafloxacin with and without food in healthy volunteers. Journal of Antimicrobial Chemotherapy 39, Suppl. B, 87-92.
7. Vincent, J., Teng, R., Dogolo, L. C., Willavize, S. A. & Friedman, H. L. (1997). Effect of trovafloxacin, a new fluoroquinolone antibiotic, on steady-state pharmacokinetics of theophylline in healthy volunteers. Journal of Antimicrobial Chemotherapy 39, Suppl. B, 81-86.
8. Höffken, G., Lode, H., Wiley, R., Glatzel, T. D., Sievers, D., Olschewski, T. et al. (1988). Pharmacokinetics and bioavailability of ciprofloxacin and ofloxacin: effect of food and antacid intake. Reviews of Infectious Diseases 10, Suppl. 1, S138-9.
9. Grasela, T. H., Schentag, J. J., Sedman, A. J., Wilton, J. H., Thomas, D. J., Schultz, R. W. et al. (1989). Inhibition of enoxacin absorption by antacids or ranitidine. Antimicrobial Agents and Chemotherapy 33, 615-7.
10. Nix, D. E., Watson, W. A., Lener, M. E., Frost, R. W., Krol, G., Goldstein, H. et al. (1989). Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clinical Pharmacology and Therapeutics 46, 700-5.
11. Nix, D. E., Wilton, J. H., Schentag, J. J., Parpia, S. H., Norman, A. & Goldstein, H. R. (1989). Inhibition of norfloxacin absorption by antacids and sucralfate. Reviews of Infectious Diseases 11, Suppl. 5, S1096.
12. Flor, S., Guay, D. R. P., Opsahl, J. A., Tack, K. & Matzke, G. R. (1990). Effects of magnesium-aluminium hydroxide and cal- cium carbonate antacids on bioavailability of ofloxacin. Antimicrobial Agents and Chemotherapy 34, 2436-8.
13. Nix, D. E., Watson, W. A., Handy, L., Frost, R. W., Rescott, D. L. & Goldstein, H. R. (1989). The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin. Pharmacotherapy 9, 377-80.
14. Garrelts, J. C., Godley, P. J., Peterie, J. D., Gerlach, E. H. & Yakshe, C. C. (1990). Sucralfate significantly reduces ciprofloxacin concentrations in serum. Antimicrobial Agents and Chemotherapy 34, 931-3.
15. Williams, E. J. (1949). Experimental designs balanced for the estimation of residual effects of treatments. Australian Journal of Scientific Research 2, 149-68.
16. Teng, R., Tensfeldt, T. G., Liston, T. E. & Foulds, G. (1996). Determination of trovafloxacin, a new oral quinolone antibiotic, in biological samples by reversed-phase high-performance liquid chromatography. Journal of Chromatography B 675, 53-9.
17. Till, A. E., Benet, L. Z. & Kwan, K. C. (1974). An integrated approach to the pharmacokinetic analysis of drug absorption. Journal of Pharmacokinetics and Biopharmaceutics 2, 525-44.
18. Noyes, M. & Polk, R. E. (1988). Norfloxacin and absorption of magnesium-aluminum. Annals of Internal Medicine 109, 168-9.
19. Radandt, J. M., Marchbanks, C. R. & Dudley, M. N. (1992). Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management. Clinical Infectious Diseases 14, 272-84.
20. Massoomi, F., Savage, J. & Destache, C. J. (1993). Omeprazole: a comprehensive review. Pharmacotherapy 13, 46-59.